Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Eli Lilly and Company has announced plans to invest $400 million in its manufacturing facilities at its Lilly Technology Center campus in Indianapolis, Indiana. The investment includes enhancements to existing manufacturing facilities that make...

Roche has agreed to acquire Promedior, a Lexington, Massachusetts-based clinical-stage biopharmaceutical company with a portfolio of molecules for treating serious fibrotic diseases, in a deal worth up to $1.4 billion. Under the agreement, Roche...

Novo Nordisk and Dicerna Pharmaceuticals, a biopharmaceutical company specializing in ribonucleic acid interference (RNAi) therapies, have formed a collaboration to discover and develop therapies for treating liver-related cardio-metabolic...

Bristol-Myers Squibb (BMS) has completed its $74-billion acquisition of Celgene following the receipt of regulatory approval from all government authorities required by the merger agreement and, as announced on April 12, 2019, approval by...

Lupin a Mumbai, India-based pharmaceutical company, has agreed to sell its entire stake in its Japanese subsidiary, Kyowa Pharmaceutical Industry Co., for JPY 57.4 billion ($527 million) to the private-equity firm, Unison Capital Partners. The...

A roundup of developments and latest news from India (Aurobindo, Biocon) and the US (Cosette Pharmaceuticals). India FDA Issues Form 483 to Aurobindo API Mfg Facilities in India The US Food and Drug Administration (FDA) has issued a Form 483...

The US Food and Drug Administration (FDA) has approved Celgene’s and Acceleron’s Pharma Reblozyl (luspatercept-aamt) for treating anemia in adult patients with beta thalassemia, a rare blood disorder, who require red-blood-cell transfusions....

Endo International, a generics and specialty branded pharmaceuticals company, has announced that Paul V. Campanelli, President and Chief Executive Officer (CEO) has notified the company’s Board of Directors of his intention to retire, and the Endo...